IONIS PHARMACEUTICALS INC — Director's Dealing 2020

Jan 31, 2020

SEC Form 4/A — Form 4/A

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2020-01-02

Reporting Person: Monia Brett P (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-02	Employee Stock Option (right to buy)	$60.89	A	148454	Acquired	2027-01-01	Common Stock (148454)	Direct

Footnotes

F1: Grant on 01/02/2020 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2020. 25% of the shares subject to the option will vest and become exercisable on 01/02/2021. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.

F2: The original Form 4 filed on January 6, 2020 reported a grant of 158,659 stock options to the reporting person which has been revised by this amendment to reflect the amount of the actual award granted to Dr. Monia.